Raymond James Trust N.A. Dexcom Inc Transaction History

Raymond James Trust N.A.

$4.55 Billion
Q3 2024

A detailed history of Raymond James Trust N.A. transactions in Dexcom Inc stock. As of the latest transaction made, Raymond James Trust N.A. holds 10,176 shares of DXCM stock, worth $793,728. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,176

Previous 26,778 62.0%

Holding current value

$793,728

Previous $3.04 Million 77.57%

% of portfolio

0.01%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$64.0 - $116.06 $1.06 Million - $1.93 Million	-16,602 Reduced 62.0%	10,176 $681,000
Q2 2024 Jul 25, 2024	BUY	$110.31 - $140.45 $113,398 - $144,382	1,028 Added 3.99%	26,778 $3.04 Million
Q1 2024 Apr 24, 2024	BUY	$114.22 - $140.1 $417,017 - $511,505	3,651 Added 16.52%	25,750 $3.57 Million
Q4 2023 Jan 10, 2024	BUY	$75.49 - $124.16 $1.28 Million - $2.11 Million	17,002 Added 333.57%	22,099 $2.74 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $65,749 - $105,378	-764 Reduced 13.04%	5,097 $475,000
Q2 2023 Aug 15, 2023	BUY	$112.47 - $130.98 $137,325 - $159,926	1,221 Added 26.31%	5,861 $753,000
Q1 2023 May 03, 2023	SELL	$104.0 - $122.92 $33,072 - $39,088	-318 Reduced 6.41%	4,640 $539,000
Q4 2022 Feb 02, 2023	SELL	$84.98 - $122.67 $52,602 - $75,932	-619 Reduced 11.1%	4,958 $562,000
Q3 2022 Oct 31, 2022	SELL	$76.35 - $94.18 $19,087 - $23,545	-250 Reduced 4.29%	5,577 $449,000
Q2 2022 Jul 14, 2022	BUY	$67.99 - $132.89 $244,356 - $477,606	3,594 Added 160.95%	5,827 $435,000
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $6,303 - $8,723	67 Added 3.09%	2,233 $1.14 Million
Q4 2021 Jan 31, 2022	SELL	$129.87 - $162.82 $6,623 - $8,303	-51 Reduced 2.3%	2,166 $1.16 Million
Q3 2021 Oct 18, 2021	BUY	$106.71 - $143.18 $4,588 - $6,156	43 Added 1.98%	2,217 $1.21 Million
Q2 2021 Jul 20, 2021	BUY	$80.99 - $107.93 $124,886 - $166,428	1,542 Added 243.99%	2,174 $928,000
Q1 2021 May 03, 2021	SELL	$84.79 - $104.74 $423 - $523	-5 Reduced 0.78%	632 $227,000
Q4 2020 Jan 13, 2021	BUY	$78.0 - $104.5 $936 - $1,254	12 Added 1.92%	637 $235,000
Q3 2020 Oct 14, 2020	SELL	$95.51 - $112.95 $2,674 - $3,162	-28 Reduced 4.29%	625 $257,000
Q2 2020 Jul 16, 2020	BUY	$62.68 - $105.34 $40,930 - $68,787	653 New	653 $264,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.

Account

Raymond James Trust N.A. Dexcom Inc Transaction History